Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex

被引:83
作者
Soto, U
Das, BC
Lengert, M
Finzer, P
zur Hausen, H
Rösl, F
机构
[1] Deutsch Krebsforschungszentrum, Forsch Schwerpunkt Angew Tumorvirol, D-69120 Heidelberg, Germany
[2] Maulana Azad Med Coll, Inst Cytol & Prevent Oncol, Div Mol Oncol, New Delhi, India
关键词
human papillomavirus; cervical cancer; AP-1; negative regulation; cytokines;
D O I
10.1038/sj.onc.1202765
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AP-1 represents a transcription factor, which plays a pivotal role in initiating and maintaining the expression of human papillomavirus (HPV) oncoproteins E6 and E7 during HPV-linked carcinogenesis of the uterine cervix. AP-1 stands as a synonym for different proteins such as c-Jun, JunB, JunD, c-Fos, FosB as well as the Fos-related antigens Fra-1 and Fra-2, which can either homo- or heterodimerize to build up a functional transcription complex, AP-1 is mainly considered as a positive regulator, which binds to cognate DNA sequences within the viral upstream regulatory region, By using nontumorigenic HeLa-fibroblast hybrids ('444'), their tumorigenic segregants ('CGL3') as well as HPV 18 positive HeLa cells as a experimental model system, evidence is provided that AP-1 composition differs considerably between these cell lines, In nuclear extracts obtained from non-tumorigenic cells, Jun-family members (in the order c-Jun > JunD > JunB) were mainly heterodimerized with Fra-1, a protein, known to be involved in the abrogation of AP-1 activity under certain experimental conditions, In contrast, Fra-1 concentration is low in extracts from tumorigenic cells, Conversely, c-Fos, the canonical dimerization partner of Jun proteins is expressed in substantial quantity in HeLa- and 'CGL3' cells, but it is completely absent in AP-1 complexes from non-tumorigenic '444' cells, Ectopical expression of c-fos under a heterologous promoter in '444'-cells induces tumorigenicity and a change of the Jun/Fra-1 ratio towards a constellation initially detected in 'CGL3'-and HeLa cells. Furthermore, conversion to tumorigenicity is accompanied with a resistance against TNF-alpha, a cytokine, capable to selectively suppress HPV 18 transcription in formerly non-malignant cells, These data propose a novel role for AP-1 as an essential component of an inter- and intracellular surveillance mechanism negatively controlling HPV transcription in non-tumorigenic cells.
引用
收藏
页码:3187 / 3198
页数:12
相关论文
共 81 条
[11]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[12]  
COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
[13]  
CRIPE T P, 1990, New Biologist, V2, P450
[14]  
CRUM CP, 1989, AM J PATHOL, V134, P1183
[15]   EXTREME INSTABILITY OF MYC MESSENGER-RNA IN NORMAL AND TRANSFORMED HUMAN-CELLS [J].
DANI, C ;
BLANCHARD, JM ;
PIECHACZYK, M ;
ELSABOUTY, S ;
MARTY, L ;
JEANTEUR, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (22) :7046-7050
[16]   HETEROGENEITY OF THE HUMAN PAPILLOMAVIRUS GROUP [J].
DEVILLIERS, EM .
JOURNAL OF VIROLOGY, 1989, 63 (11) :4898-4903
[17]   Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro [J].
Durst, M ;
Seagon, S ;
Wanschura, S ;
zurHausen, H ;
Bullerdiek, J .
CANCER GENETICS AND CYTOGENETICS, 1995, 85 (02) :105-112
[18]  
DURST M, 1987, ONCOGENE, V1, P251
[19]  
DURST M, 1991, J VIROL, V65, P796
[20]   THE HUMAN PAPILLOMA VIRUS-16 E7-ONCOPROTEIN IS ABLE TO BIND TO THE RETINOBLASTOMA GENE-PRODUCT [J].
DYSON, N ;
HOWLEY, PM ;
MUNGER, K ;
HARLOW, E .
SCIENCE, 1989, 243 (4893) :934-937